Effect of Methotrexate on the Relation Dose-Effect of Infliximab in Ankylosing Spondylitis
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Infliximab (Primary) ; Methotrexate
- Indications Ankylosing spondylitis
- Focus Pharmacokinetics
- Acronyms SPAXIM
- 04 Feb 2010 Actual end date (Dec 2009) added and additional lead trial centre (Institut National de la Sante Et de la Recherche Medicale) identified as reported by ClinicalTrials.gov.
- 04 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2007 New trial record.